R 7118
Alternative Names: R-7118Latest Information Update: 15 Apr 2016
Price :
$50 *
At a glance
- Originator Roche
- Class Antipsychotics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 31 Dec 2006 Phase-I clinical trials in Schizophrenia in Switzerland (unspecified route)